Aspergillosis: all 202 studies
Page 2 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in AdultsTerminatedNCT03327727Phase 2
- Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary AspergillosisStatus unknownNCT03267394
- Clinical Implications of Azole-Resistant Aspergillosis in Hematological MalignancyCompletedNCT03221075
- A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating AsthmaCompletedNCT03133299Phase 2/3
- PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.CompletedNCT03121235
- Drug/Drug Interactions With F901318WithdrawnNCT03095547Phase 1
- Pharmacokinetics of IV FormulationWithdrawnNCT03076905Phase 1
- Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological PatientsCompletedNCT03067350
- Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter StudyStatus unknownNCT03027089
- Surveillance of Azole Resistance in Aspergillus Isolates in TaiwanStatus unknownNCT03024281
- Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell TransplantationStatus unknownNCT03014934
- Novel Biomarkers for Invasive AspergillosisTerminatedNCT03004092Not applicable
- PET/CT Guided Antifungal Stewardship in Invasive Pulmonary AspergillosisCompletedNCT02955966Not applicable
- Radiolabelled IV and Oral Metabolism Study of F901318WithdrawnNCT02912026Phase 1
- Invasives Aspergillosis in Acute Myeloid LeukemiaCompletedNCT02900430
- Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsWithdrawnNCT02856178Phase 1/2
- Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic FibrosisCompletedNCT02853175
- Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.CompletedNCT02851680Not applicable
- Evaluation of Immediate Release TabletCompletedNCT02808741Phase 1
- An Evaluation of Sequential Computed Tomography of the Chest in Management of Invasive Pulmonal Aspergillosis in Neutropenic Patients With Haematological MalignanciesStatus unknownNCT02773342
- Multiple Ascending Oral Dose Study of F901318 in Healthy SubjectsCompletedNCT02737371Phase 1
- Study of Potential for Interaction of Fluconazole With F901318CompletedNCT02730442Phase 1
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945CompletedNCT02715570Phase 1
- Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a ProbeCompletedNCT02680808Phase 1
- Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus SppTerminatedNCT02646800Phase 4
- Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive AspergillosisTerminatedNCT02646774Phase 4
- Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.CompletedNCT02569879
- A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary AspergillosisCompletedNCT02440009Phase 2/3
- Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral AdministrationTerminatedNCT02396225Not applicable
- Single Ascending Oral Dose Study of F901318CompletedNCT02394483Phase 1
- F901318 Multiple Ascending Dose StudyCompletedNCT02342574Phase 1
- Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).CompletedNCT02273661Phase 2
- Voriconazole for IPA in Chinese Patients With COPDStatus unknownNCT02234739Phase 4
- Exhaled Breath Analysis in the Early Detection of AspergillosisCompletedNCT02106117
- Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker TestingStatus unknownNCT02104479
- CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult PatientsStatus unknownNCT02100761
- Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter StudyCompletedNCT02058316
- Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised PatientsStatus unknownNCT01902030
- Individualisation of Voriconazole Antifungal Therapy Antifungal TherapySuspendedNCT01887457Phase 2
- Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill PatientsCompletedNCT01866020
- A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary AspergillosisCompletedNCT01857479Phase 2/3
- Aspergillus PCR Early Detection in High Risk Oncohematological PatientsCompletedNCT01742026
- Protocol TARC-ABPACompletedNCT01710930Not applicable
- Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised PatientsStatus unknownNCT01695512
- Diagnostic Study of Biomarkers in BAL of ICU Patients With Lung InfiltratesStatus unknownNCT01695499
- UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer PatientsWithdrawnNCT01622595
- Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary AspergillosisCompletedNCT01621321Phase 2/3
- Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System AspergillosisStatus unknownNCT01617759
- Diagnostic Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid SamplesStatus unknownNCT01614145
- ATCF (Azole Therapy in Cystic Fibrosis)CompletedNCT01576315Phase 2
- Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal TherapyCompletedNCT01448226
- Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage SamplesCompletedNCT01430663
- Application of an Electronic Nose in the Early Detection of ASpergillosisCompletedNCT01395446
- Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary AspergillosisCompletedNCT01321827Phase 2/3
- Pre-hospital Risk Factors for Invasive Fungal InfectionStatus unknownNCT01315925
- Diagnosis of Invasive Pulmonary Aspergillosis by Direct Lung Tissue Aspergillus Galactomannan Antigen Detection From Aspirate by Ultrasound-guided Fine Needle AspirationStatus unknownNCT01301755
- Efficacy Of Itraconazole In Chronic Cavitary Pulmonary AspergillosisCompletedNCT01259336Phase 4
- Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary AspergillosisCompletedNCT01247142
- Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive AspergillosisWithdrawnNCT01207128Phase 2
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsWithdrawnNCT01188759Phase 3
- Radiologic Features of Invasive Pulmonary AspergillosisCompletedNCT01178177
- Correlation Between Circulating Galactomannan and Beta-D-glucan and Clinical Outcome of Invasive AspergillosisStatus unknownNCT01176071
- Galactomannan Antigen in Bronchoalveolar Lavage in the Diagnosis of Invasive Aspergillosis in Neutropenic PatientsCompletedNCT01128907
- Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary MycosisStatus unknownNCT01125644Phase 3
- Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell TransplantationCompletedNCT01040156
- Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal TransplantationStatus unknownNCT00986713Phase 4
- Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer PatientsTerminatedNCT00982540Not applicable
- Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary AspergillosisCompletedNCT00974766Phase 2/3
- Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary ZygomycosisCompletedNCT00923832
- Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)CompletedNCT00906568
- Surveillance for Nosocomial Infections in Pediatric Cancer PatientsStatus unknownNCT00843804
- Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Status unknownNCT00838643
- Diagnostic and Management Strategies for Invasive AspergillosisCompletedNCT00816088
- A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal InfectionsCompletedNCT00647907Phase 4
- Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPACompletedNCT00585364
- Prophylaxis of Fungal Invasive Infections in LeukemiaCompletedNCT00501098Phase 2
- Surveillance of Fungal Infections During Construction ActivityCompletedNCT00473252
- Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other DiseaseStatus unknownNCT00462657Not applicable
- Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCTStatus unknownNCT00460330
- A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisWithdrawnNCT00423163Phase 4
- Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary AspergillosisCompletedNCT00391014Phase 2
- Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal InfectionCompletedNCT00388167
- Micafungin Salvage Mono-therapy in Invasive AspergillosisTerminatedNCT00376337Phase 2
- To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment EarlyCompletedNCT00361517Phase 3
- COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive AspergillosisCompletedNCT00334412Phase 4
- Inhalation of Liposomal Amphotericin B to Prevent Invasive AspergillosisCompletedNCT00263315Phase 2/3
- Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant RecipientsCompletedNCT00177827
- A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology PatientsCompletedNCT00163722Phase 3
- Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial TreatmentCompletedNCT00158730Phase 3
- Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantCompletedNCT00110045Phase 2
- Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)CompletedNCT00082524Phase 2
- MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)CompletedNCT00076869Phase 2
- Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal InfectionsCompletedNCT00059878Phase 2
- Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for AspergillosisTerminatedNCT00047827Phase 2
- A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).CompletedNCT00037206Phase 2/3
- Study of FK463 for the Treatment of Invasive AspergillosisCompletedNCT00036166Phase 2
- Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
- A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of AspergillomaCompletedNCT00005668Phase 2
- Comparison of Voriconazole and Amphotericin B in Treating Patients With AspergillosisCompletedNCT00003031Phase 3
- Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 3